FDA to Revoke Exemption for Certain Pseudoephedrine Products Under the FD&C Act

Summary

The US Food and Drug Administration (FDA) is set to remove the exemption for certain pseudoephedrine products marketed under the Federal Food, Drug, and Cosmetic Act (FD&C Act), a move aimed at reducing the production and sale of these products, which are often used to manufacture methamphetamine.